| pubmed-article:15464240 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15464240 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:15464240 | lifeskim:mentions | umls-concept:C0025519 | lld:lifeskim |
| pubmed-article:15464240 | lifeskim:mentions | umls-concept:C0009510 | lld:lifeskim |
| pubmed-article:15464240 | lifeskim:mentions | umls-concept:C0336562 | lld:lifeskim |
| pubmed-article:15464240 | lifeskim:mentions | umls-concept:C2721373 | lld:lifeskim |
| pubmed-article:15464240 | lifeskim:mentions | umls-concept:C0457083 | lld:lifeskim |
| pubmed-article:15464240 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15464240 | pubmed:dateCreated | 2004-10-6 | lld:pubmed |
| pubmed-article:15464240 | pubmed:abstractText | The use of cell lines in bioartificial liver support systems (BALSS) to treat fulminant hepatic failure (FHF) is hindered by their reduced metabolic functions, which could be further decreased by the patient's serum/plasma. Hence, the aim of this study was to (i) test the effect of the FHF serum on C3A cell metabolism; (ii) precondition the cells to improve their metabolic capacity. | lld:pubmed |
| pubmed-article:15464240 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15464240 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15464240 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15464240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15464240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15464240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15464240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15464240 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15464240 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:15464240 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:15464240 | pubmed:author | pubmed-author:NelsonLeonard... | lld:pubmed |
| pubmed-article:15464240 | pubmed:author | pubmed-author:PlevrisJohn... | lld:pubmed |
| pubmed-article:15464240 | pubmed:author | pubmed-author:HayesPeter... | lld:pubmed |
| pubmed-article:15464240 | pubmed:author | pubmed-author:FilippiCéline... | lld:pubmed |
| pubmed-article:15464240 | pubmed:author | pubmed-author:KeatchSteven... | lld:pubmed |
| pubmed-article:15464240 | pubmed:author | pubmed-author:RangarDeepaD | lld:pubmed |
| pubmed-article:15464240 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15464240 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:15464240 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15464240 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15464240 | pubmed:pagination | 599-605 | lld:pubmed |
| pubmed-article:15464240 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:meshHeading | pubmed-meshheading:15464240... | lld:pubmed |
| pubmed-article:15464240 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15464240 | pubmed:articleTitle | Improvement of C3A cell metabolism for usage in bioartificial liver support systems. | lld:pubmed |
| pubmed-article:15464240 | pubmed:affiliation | Department of Hepatology, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB Scotland, UK. celine.filippi@ed.ac.uk | lld:pubmed |
| pubmed-article:15464240 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15464240 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15464240 | lld:pubmed |
